Abstract
Giant cell tumor of bone (GCTB) in skeletally immature patients is rare, and little is known regarding how fast GCTB can grow. We report a case of a 10-year-old skeletally immature girl with pathologically proven GCTB with obvious growth plate invasion that showed surprisingly rapid growth over only 14 days. A radiograph of the left knee revealed well-circumscribed, geographic bone destruction at the distal metaphysis of the femur with a focal cortical defect, suggesting a pathologic fracture. No abnormal mineralization or periosteal reaction was seen. A CT without contrast and an MRI demonstrated a homogeneous lesion with cortical disruption posteriorly and laterally with a slight soft tissue extension. Biopsy showed numerous multinucleated giant cells and spindle-shaped mononuclear cells without any sign of malignancy, suggesting GCTB. However, rapid lesion enlargement and destruction of the surrounding cortex were noted 14 days after biopsy. Considering the amount of bone destruction, traditional treatment of curettage and bone cement would not suffice to sustain structural strength. In addition, considering the patient's age, the tumor location, and the aggressive course, a malignant tumor, especially a giant cell-rich osteosarcoma, could not be excluded. Therefore, en bloc resection, including the growth plate and prosthetic replacement, were performed. Confirmation of GCTB was made from a pathologic evaluation, and a breach to the growth plate was identified. Since very little inflammatory reaction, degenerative change, or aneurysmal, bone, cyst-like change was found, the growth plate invasion was confirmed as due to GCTB extension, not due to the preoperative biopsy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Kransdorf MJ, Sweet DE, Buetow PC, Giudici MA, Moser RP. Giant cell tumor in skeletally immature patients. Radiology. 1992;184(1):233–7.
Fletcher CDM, Bridge JA, Hogendoorn P, Mertens F. WHO classification of tumour of soft tissue and bone. 4th ed. Lyon: IARC Press; 2013. p. 321–4.
Unni KK, Inward CY. Dahlin’s bone tumors. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2009. p. 225–42.
Cummins CA, Scarborough MT, Enneking WF. Multicentric giant cell tumor of bone. Clin Orthop Relat Res. 1996;322:245–52.
Gandhe A, Sankhe A, Aeron G, Joshi A. Epiphyseal giant cell tumour in an immature skeleton. Br J Radiol. 2008;81(963):75–8.
Kuettner KE, Pauli BU, Soble L. Morphological studies on the resistance of cartilage to invasion by osteosarcoma cells in vitro and in vivo cells in vitro and in vivo. Cancer Res. 1978;38:277–87.
Langer R, Brem H, Falterman K, Klein MFJ. Isolations of a cartilage factor that inhibits tumor neovascularization. Science. 1976;193(4247):70–2.
Panuel M, Gentet JC, Scheiner C, Jouve JL, Bollini G, Petit P, et al. Physeal and epiphyseal extent of primary malignant bone tumors in childhood - Correlation of preoperative MRI and the pathologic examination. Pediatr Radiol. 1993;23(6):421–4.
Puri A, Agarwal MG, Shah M, Jambhekar NA, Anchan CBS. Giant cell tumor of bone in children and adolescents. J Pediatr Orthop. 2007;27(6):635–9.
Levine E, De Smet AA, Neff JR. Role of radiologic imaging in management planning of giant cell tumor of bone. Skelet Radiol. 1984;12(2):79–89.
Picci P, Manfrini M, Zucchi V, Gherlinzoni F, Rock M, Bertoni F, et al. Giant-cell tumor of bone in skeletally immature patients. J Bone Joint Surg. 1983;65-A(4):486–90.
Moser RP, Kransdorf MJ, Gilkey FW, Manaster BJ. Giant cell tumor of the upper extremity. RadioGraphics. 1990;10:83–102.
Murphey MD, Nomikos GC, Donald J, Gannon MCFH, Thomas, H, Kransdorf MJ. From the archives of the AFIP. Imaging of giant cell tumor and giant cell reparative granuloma of bone: Radiologic-pathologic correlation. RadioGraphics. 2001;21(5):1283–309.
Chakarun CJ, Forrester DM, Gottsegen CJ, Patel DB, White EA, Matcuk GR. Giant cell tumor of bone: review, mimics, and new developments in treatment. RadioGraphics. 2013;33(1):197–211.
Wang H-C, Chien S-H, Lin G-T. Management of grade III giant cell tumors of bones. J Surg Oncol. 2005;92(1):46–51.
Branstetter DG, Nelson SD, Manivel JC, Blay J-Y, Chawla S, Thomas DM, et al. Denosumab induces tumor reduction and bone formation in patients with giant-cell tumor of bone. Clin Cancer Res. 2012;18(16):4415–24.
Chawla S, Henshaw R, Seeger L, Choy E, Blay JY, Ferrari S, et al. Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study. Lancet Oncol. 2013;14(9):901–8.
Thomas D, Henshaw R, Skubitz K, Chawla S, Staddon A, Blay J-Y, et al. Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study. Lancet Oncol. 2010;11(3):275–80.
Acknowledgments
We thank Dr. Jay Starkey for his valuable support in preparing this manuscript, Dr. Rikuo Machinami., Dr. Hiroaki Kanda, and Dr. Yoshiya Sugiura for the pathological diagnosis.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The author(s) declare that they have no competing interests.
Rights and permissions
About this article
Cite this article
Akaike, G., Ueno, T., Matsumoto, S. et al. Rapidly growing giant cell tumor of bone in a skeletally immature girl. Skeletal Radiol 45, 567–573 (2016). https://doi.org/10.1007/s00256-015-2276-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00256-015-2276-4